Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 13 Oct 2020 for AKCEA THERAPEUTICS, INC., €768k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Michael Dennis Price: trading record in brief
Filings by Michael Dennis Price span 2 companies, the busiest being Akcea Therapeutics, Inc. and Novelion Therapeutics Inc. The record holds 4 filings, for trades running from 27 November 2018 to 12 October 2020.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 13 October 2020: a transaction of €768k, in Akcea Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael Dennis Price
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
50,000 shares@ US$18.15100.0% of flowCommon StockSEC:0001209191-20-054622:0
50,000 shares0Common StockSEC:0001209191-20-030621:0
3,926 shares@ US$0.7663.0% of flowCommon StockSEC:0001104659-19-051596:0
1,963 shares@ US$0.9237.0% of flowCommon StockSEC:0001104659-18-070335:0
4 of 4 declarations
